U.S. Congress - S.3187 Synthetic Drug Abuse Prevention Act of 2012
S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)
All Bill Titles
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
- Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
- Short: Medical Device User Fee Amendments of 2012 as passed senate.
- Short: Generic Drug User Fee Amendments of 2012 as passed senate.
- Short: Biosimilar User Fee Act of 2012 as passed senate.
- Short: Food and Drug Administration Safety and Innovation Act as passed senate.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Safety and Innovation Act as passed house.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as enacted.
- Short: Biosimilar User Fee Act of 2012 as enacted.
- Short: Generic Drug User Fee Amendments of 2012 as enacted.
- Short: Medical Device User Fee Amendments of 2012 as enacted.
- Short: Prescription Drug User Fee Amendments of 2012 as enacted.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| Number | Date Offered | Status | Purpose |
|---|---|---|---|
| S.Amdt.2110 | May 17th | Offered | Amendment information not available. (View on THOMAS) |
| S.Amdt.2107 | May 17th | Offered | To allow the importation by individuals of safe and affordable drugs from Canada. (View on THOMAS) |
| S.Amdt.2111 | May 17th | Offered | To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market. (View on THOMAS) |
| S.Amdt.2108 | May 17th | Offered | To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval. (View on THOMAS) |
| S.Amdt.2109 | May 17th | Offered | To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws. (View on THOMAS) |
| S.Amdt.2115 | May 21st | Offered | Amendment information not available. (View on THOMAS) |
| S.Amdt.2118 | May 21st | Offered | Amendment information not available. (View on THOMAS) |
| S.Amdt.2117 | May 21st | Offered | Amendment information not available. (View on THOMAS) |
| S.Amdt.2116 | May 21st | Offered | Amendment information not available. (View on THOMAS) |
| S.Amdt.2114 | May 21st | Offered | Amendment information not available. (View on THOMAS) |
Vote on This Bill
-
Share This Bill
More Share via Email
